Core Viewpoint - The share price of CTO Realty Growth, Inc. significantly declined following allegations from Wolfpack Research regarding misleading statements about dividend sustainability and questionable financial practices [1][4]. Group 1: Allegations and Investigations - Wolfpack Research published a report accusing CTO of misleading investors about its dividend sustainability and engaging in dubious financial activities, leading to a decline in share price [1][4]. - Hagens Berman, a national shareholders rights firm, has initiated an investigation into CTO's practices and potential violations of securities laws, urging affected investors to come forward [2][3]. - The investigation focuses on CTO's adherence to accounting rules and the use of non-GAAP accounting metrics, particularly concerning the quality of its real estate portfolio and reported asset values [3][5]. Group 2: Financial Practices and Management - Wolfpack's report claims that CTO's management has misrepresented the quality of its properties, highlighting that some are in extreme financial distress and that the company relies on dilution to cover a $38 million dividend shortfall [4][5]. - The report criticizes CTO's definition of Adjusted Funds From Operation (AFFO), stating it excludes recurring capital expenditures, which is not consistent with industry peers, and suggests that management has inflated performance bonuses by $8 million [5][8]. - Allegations include misleading investors about dividend sustainability while enriching management and engaging in questionable accounting practices, such as using a sham loan to mask a tenant's failure [8].

Company Overview - Encompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with approximately 166 facilities across 38 states [3] - The company provides intensive post-acute care, including physical, occupational, respiratory, and speech therapy for patients recovering from major illnesses and injuries [3] Allegations of Wrongdoing - An article published by The New York Times on July 15, 2025, raised patient safety concerns at Encompass rehabilitation hospitals, stating that the company owns 34 of the 41 inpatient rehab facilities flagged by Medicare for having "statistically significantly worse rates of potentially preventable readmissions" [4] - Specific incidents mentioned include fatal carbon monoxide poisoning, medication errors, and bed alarm failures [4] Market Reaction - Following the publication of the article, Encompass's stock price fell by $12.39 per share, or 10.35%, closing at $107.28 per share on July 15, 2025 [5]

Core Viewpoint - Encompass Health Corporation is under investigation for potential violations of federal securities laws and unlawful business practices following reports of safety concerns at its rehabilitation hospitals [1][3]. Group 1: Investigation Details - Kirby McInerney LLP is investigating claims against Encompass Health and its officers regarding possible violations of federal securities laws [1]. - The investigation was prompted by a New York Times article that highlighted significant safety issues at Encompass Health's hospitals, including high rates of preventable readmissions and serious operational mistakes [3]. Group 2: Financial Impact - Following the news of the investigation and safety concerns, Encompass Health's stock price fell by $12.39, approximately 10.4%, closing at $107.28 per share on July 15, 2025 [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Sable Offshore Corp. for possible violations of federal securities laws and unlawful business practices [2] Group 1: Company Operations - On May 19, 2025, Sable announced the resumption of oil production from one of its offshore platforms related to the Las Flores pipeline as of May 15, 2025 [3] - On May 21, 2025, Sable priced its public offering of 8,695,654 shares at $29.50 per share, resulting in gross proceeds of approximately $295 million [4] Group 2: Regulatory Issues - The California State Land Commission warned Sable on May 23, 2025, that its press release mischaracterized recent activities, causing public confusion and raising questions about the company's intentions [5] - On May 28, 2025, a preliminary injunction was approved by the Santa Barbara County Superior Court regarding Sable's maintenance and repair work in the coastal zone, leading to a decline in Sable's stock price by $5.04 per share, or approximately 15%, from $32.93 to $27.89 [6]

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of misleading investors about its financial health and growth prospects, leading to a significant drop in stock price [1][3][5]. Group 1: Lawsuit Details - The lawsuit, titled Lunstrum v. Centene Corporation, seeks to represent investors who acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934 [1][2]. - The allegations center around claims that Centene and its executives provided an overly optimistic view of the company's financial situation, particularly regarding revenue outlook and enrollment rates [3][4]. Group 2: Financial Impact - On July 1, 2025, Centene withdrew its 2025 guidance, stating that market growth across 22 states, which accounts for 72% of its marketplace membership, was "lower than expected," leading to a revised guidance of approximately $1.8 billion or an adjusted diluted EPS of $2.75 [4]. - Following this announcement, Centene's stock price fell by more than 40%, resulting in billions of dollars in lost shareholder value [5]. Group 3: Investigative Actions - Hagens Berman, a national shareholders rights firm, is investigating the claims and encourages affected investors to report their losses [2][6]. - The firm suggests that if the allegations are proven true, they indicate a disconnect between Centene's public statements and its actual performance metrics [6].

Core Viewpoint - Berger Montague is investigating potential securities law violations involving Petco Health and Wellness Company, with a class action lawsuit filed for investors who acquired Petco securities between January 14, 2021, and June 5, 2025 [1][2] Group 1: Legal Investigation and Class Action - A class action lawsuit has been initiated on behalf of investors who purchased Petco securities during the specified Class Period [1][2] - Investors have until August 29, 2025, to seek appointment as lead plaintiff representative of the class [2] Group 2: Allegations Against Petco - The complaint alleges that Petco made materially false and misleading statements regarding its pandemic-related advantages and the sustainability of its premium pet food business model [3] - It is claimed that Petco overstated its ability to achieve profitable growth while downplaying operational challenges [3] - These alleged misrepresentations resulted in significant declines in Petco's stock price, including a drop of over 20% on August 24, 2023, following a downward revision of financial guidance [3]

Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. for alleged violations of securities laws, specifically regarding misleading statements made by the company during the class period from January 14, 2021, to June 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Petco overstated the impact of its differentiated products and downplayed challenges that negatively affected sales [2]. - The company is accused of misrepresenting its ability to achieve sustainable growth, leading to materially incorrect and misleading statements throughout the class period [2]. Group 2: Law Firm Information - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through balanced counseling and aggressive advocacy [3]. - The firm represents some of the largest hedge funds and alternative asset managers, indicating a strong background in handling valuable litigation claims [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating KinderCare Learning Companies, Inc. (NYSE: KLC) for potential violations of securities laws related to misrepresentation or failure to disclose material information to investors [1] Group 1: Investigation Details - The investigation focuses on whether KLC or its executives misrepresented or failed to timely disclose important information to investors [1] - Investors who purchased KLC securities and suffered losses are encouraged to join the investigation [2] Group 2: Whistleblower Information - Individuals with nonpublic information about KLC are advised to consider assisting the investigation or utilizing the SEC Whistleblower program, which may offer rewards up to 30% of successful recoveries [3] Group 3: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights, with offices across multiple states [4] - The firm has been ranked in the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, recovering approximately $90.725 million for clients [5]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential violations of securities laws by The J. M. Smucker Company and its executives regarding misrepresentation or failure to disclose material information to investors [1] Group 1: Investigation Details - The investigation is focused on whether The J. M. Smucker Company misrepresented or failed to timely disclose material information to investors [1] - Investors who purchased SJM securities and suffered losses are encouraged to join the investigation [2] - Individuals with relevant nonpublic information are advised to consider assisting the investigation or utilizing the SEC Whistleblower program, which may offer rewards up to 30% of any successful recovery [3] Group 2: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with multiple offices across the United States, representing both individual and institutional investors [4] - The firm has been ranked in the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, having recovered approximately $90,725,000 for clients in lead or co-lead counsel cases [5]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Bitfarms Ltd. regarding a class action lawsuit due to alleged misleading statements and deficiencies in financial reporting during the specified class period [1]. Group 1: Allegations Against Bitfarms Ltd. - The complaint alleges that Bitfarms maintained deficient internal controls over financial reporting [1] - It is claimed that the company incorrectly categorized proceeds from the sale of digital assets as cash flow from operating activities instead of investing activities [1] - The company allegedly overstated its ability to remediate material weaknesses in its internal controls related to the classification of the 2021 Warrants [1] - These errors reportedly caused Bitfarms to misstate various items in previously issued financial statements, which may need to be restated [1] - As a result, the company's public statements were materially false and misleading throughout the relevant period [1] Group 2: Class Action Participation - Shareholders who purchased shares of Bitfarms during the class period from March 21, 2023, to December 9, 2024, are encouraged to register for the class action [2] - The deadline for shareholders to seek lead plaintiff status is July 8, 2025 [2] - There is no cost or obligation for shareholders to participate in the case, and they will receive status updates through portfolio monitoring software [2] Group 3: About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and fraud [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3]